Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

EU Training Network in understanding the molecular regulation and the role of endo-lysosomal processes in cardio-metabolic diseases

Descripción del proyecto

El papel del sistema endolisosómico en las enfermedades cardiometabólicas

La homeostasis metabólica depende del sistema endolisosómico, que obtiene los lípidos y los nutrientes esenciales para satisfacer las necesidades celulares. Los defectos en este sistema están asociados a las enfermedades cardiovasculares, la diabetes y otros trastornos metabólicos. El objetivo del proyecto EndoConnect, financiado con fondos europeos, es comprender la interconexión entre el sistema endolisosómico y el metabolismo. Los científicos se centrarán en la regulación de los procesos endolisosómicos, su papel en la eficacia terapéutica y los mecanismos que contribuyen a las enfermedades. Además, a través de un programa de formación interdisciplinaria, el proyecto proporcionará a investigadores noveles competencias científicas, técnicas y transferibles de vanguardia para que desarrollen su trayectoria profesional en este campo.

Objetivo

The endo-lysosomal system is essential to acquire lipids and nutrients according to the need of the cell and, subsequently, to maintain metabolic homeostasis. The strong connection between the endo-lysosomal system and metabolism is reflected in the observations that defects in this system are correlated with cardio-metabolic disorders, such as cardiovascular disease, type 2 diabetes and non-alcoholic fatty liver disease. The molecular mechanisms that interconnect the endo-lysosomal system with metabolism are, however, poorly understood. This can be largely explained by the fact that (1) endo-lysosomal and metabolic research are carried out independent of each other and (2) the number of model systems to study endo-lysosomal processes at an organismal and clinical level are limited. It is the ambition of EndoConnect to change this by bringing top scientists and industrial partners together to train early stage researchers in interdisciplinary research, with the focus on translating key findings from cellular and animal models to patients with cardio-metabolic diseases. It is our mission to: (1) understand the molecular organization and regulation of endo-lysosomal processes, (2) elucidate how metabolism and endo-lysosomal processes are intertwined, (3) understand how defects in the endo-lysosomal system contribute to the development of cardio-metabolic diseases and, finally, (4) how the endo-lysosomal system contributes to the efficiency of therapeutics. EndoConnect will provide an international training program for early stage researchers to acquire knowledge and state-of-the-art scientific, technical, and transferable skills to connect molecular and cell biology research with physiology and biomedical research towards translation. We expect that EndoConnect will increase our understanding of the molecular interrelation of the endo-lysosomal system with cardio-metabolic diseases, which will pave the road for novel diagnostics and therapeutics.

Coordinador

ACADEMISCH ZIEKENHUIS GRONINGEN
Aportación neta de la UEn
€ 531 239,76
Dirección
HANZEPLEIN 1
9713 GZ Groningen
Países Bajos

Ver en el mapa

Región
Noord-Nederland Groningen Overig Groningen
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 531 239,76

Participantes (11)